Michela Cinquini

The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application

Silvia Minozzi, Michela Cinquini, Silvia Gianola et al. · Journal of Clinical Epidemiology · 2020 · 455 citations

Public Health, Biostatistics, Evidence-based Practice +13

European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk

Joachim Schüz, Carolina Espina, Patricia Villain et al. · Cancer Epidemiology · 2015 · 281 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Malignant peritoneal mesothelioma: a multicenter study on 81 cases

Vincenzo de Pangher Manzini, Leonardo Recchia, Mara A. Cafferata et al. · Annals of Oncology · 2009 · 124 citations · Full text

Medicine, Oncology, Surgery +11

Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability

Rita Banzi, Michela Cinquini, Marien González‐Lorenzo et al. · Journal of Clinical Epidemiology · 2018 · 95 citations

Management, Quality Management, Quality Improvement +13

Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

Silvia Minozzi, Stefanos Bonovas, Theodore Lytras et al. · Expert Opinion on Drug Safety · 2016 · 75 citations

Medicine, Clinical Sciences, Internal Medicine +11